Andrea Brech
Family · Jonesboro, ARNPI 1942997978
Payments from drug & device makers
Across 145 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$331
- AbbVie$210
- Astellas Pharma US Inc$207
- GSK$203
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$178
- Boehringer Ingelheim$171
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,692100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $331 |
| AbbVie | 14 | $210 |
| Astellas Pharma US Inc | 10 | $207 |
| GSK | 13 | $203 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $178 |
| Boehringer Ingelheim | 9 | $171 |
| Lilly USA, LLC | 9 | $139 |
| Dexcom, Inc. | 3 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $128 |
| Amgen | 7 | $112 |
| Idorsia Pharmaceuticals US Inc | 1 | $94 |
| Sumitomo Pharma America, Inc. | 5 | $91 |
| Novo Nordisk | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 6 | $62 |
| Lundbeck LLC | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Averitas Pharma Inc. | 2 | $39 |
| Sanofi-aventis U.S. LLC | 1 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Medtronic | 2 | $37 |
| Bayer | 2 | $36 |
| Edwards Lifesciences | 1 | $31 |
| Novartis | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Viatris Specialty LLC | 1 | $27 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Corium, LLC | 2 | $19 |
| Pfizer | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Boston Scientific | 1 | $13 |
How this compares
$2,692 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 11 | $1,572 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 134 | $1,506 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $1,368 |
| Methylprednisolone | 140 | $913 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $791 |
| Doxycycline Hyclate | 80 | $776 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 41 | $755 |
| Cefdinir | 27 | $629 |
| Fluticasone Propionate | 43 | $578 |
| Sucralfate | 15 | $516 |
| Nystatin | 23 | $486 |
| Cephalexin | 41 | $404 |
| Amlodipine Besylate | 32 | $346 |
| Levothyroxine Sodium | 25 | $324 |
| Ondansetron OdtOndansetron | 27 | $264 |
Paid to pharmacies, not to this prescriber.
Other family in Jonesboro
- Stefanie BrackinJonesboro$51K
- Jessica MatthewsJonesboro$19K
- Kimberly DanielsJonesboro$14K
- Kimberly RoddyJonesboro$12K
- Christopher JordanJonesboro$12K
- Amber ToombsJonesboro$12K
- Tracy ThompsonJonesboro$11K
- Ashley SheltonJonesboro$10K
- Steven VanderbiltJonesboro$10K
- Erika VanceJonesboro$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.